The role of Piezo1 mechanotransduction in high-grade serous ovarian cancer: Insights from an in vitro model of collective detachment
- PMID: 38669327
- PMCID: PMC11051664
- DOI: 10.1126/sciadv.adl4463
The role of Piezo1 mechanotransduction in high-grade serous ovarian cancer: Insights from an in vitro model of collective detachment
Abstract
Slowing peritoneal spread in high-grade serous ovarian cancer (HGSOC) would improve patient prognosis and quality of life. HGSOC spreads when single cells and spheroids detach, float through the peritoneal fluid and take over new sites, with spheroids thought to be more aggressive than single cells. Using our in vitro model of spheroid collective detachment, we determine that increased substrate stiffness led to the detachment of more spheroids. We identified a mechanism where Piezo1 activity increased MMP-1/MMP-10, decreased collagen I and fibronectin, and increased spheroid detachment. Piezo1 expression was confirmed in omental masses from patients with stage III/IV HGSOC. Using OV90 and CRISPR-modified PIEZO1-/- OV90 in a mouse xenograft model, we determined that while both genotypes efficiently took over the omentum, loss of Piezo1 significantly decreased ascitic volume, tumor spheroids in the ascites, and the number of macroscopic tumors in the mesentery. These results support that slowing collective detachment may benefit patients and identify Piezo1 as a potential therapeutic target.
Figures
![Fig. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11051664/bin/sciadv.adl4463-f1.gif)
![Fig. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11051664/bin/sciadv.adl4463-f2.gif)
![Fig. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11051664/bin/sciadv.adl4463-f3.gif)
![Fig. 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11051664/bin/sciadv.adl4463-f4.gif)
![Fig. 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11051664/bin/sciadv.adl4463-f5.gif)
Similar articles
-
Alternatively activated macrophage-derived secretome stimulates ovarian cancer spheroid spreading through a JAK2/STAT3 pathway.Cancer Lett. 2019 Aug 28;458:92-101. doi: 10.1016/j.canlet.2019.05.029. Epub 2019 May 24. Cancer Lett. 2019. PMID: 31129149 Free PMC article.
-
Establishment and Characterization of the Novel High-Grade Serous Ovarian Cancer Cell Line OVPA8.Int J Mol Sci. 2018 Jul 17;19(7):2080. doi: 10.3390/ijms19072080. Int J Mol Sci. 2018. PMID: 30018258 Free PMC article.
-
Tumor cell‑fibroblast heterotypic aggregates in malignant ascites of patients with ovarian cancer.Int J Mol Med. 2019 Dec;44(6):2245-2255. doi: 10.3892/ijmm.2019.4361. Epub 2019 Oct 2. Int J Mol Med. 2019. PMID: 31638162 Free PMC article.
-
HMGA2 and high-grade serous ovarian carcinoma.J Mol Med (Berl). 2013 Oct;91(10):1155-65. doi: 10.1007/s00109-013-1055-8. Epub 2013 May 19. J Mol Med (Berl). 2013. PMID: 23686260 Review.
-
The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models.Biochim Biophys Acta Rev Cancer. 2024 Jan;1879(1):189052. doi: 10.1016/j.bbcan.2023.189052. Epub 2023 Dec 12. Biochim Biophys Acta Rev Cancer. 2024. PMID: 38097143 Review.
References
-
- O'Shea A. S., Clinical staging of ovarian cancer. Methods Mol. Biol. 2424, 3–10 (2022). - PubMed
-
- Kenny H. A., Chiang C. Y., White E. A., Schryver E. M., Habis M., Romero I. L., Ladanyi A., Penicka C. V., George J., Matlin K., Montag A., Wroblewski K., Yamada S. D., Mazar A. P., Bowtell D., Lengyel E., Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion. J. Clin. Invest. 124, 4614–4628 (2014). - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials